MannKind Corporation ( MNKD) - Key Metrics
MNKD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.35 | -$0.06 | -$0.06 | -$0.08 |
| 2026Q1 | $0.29 | -$0.05 | -$0.02 | -$0.02 |
| 2025Q4 | $0.37 | -$0.05 | -$0.03 | -$0.03 |
| 2025Q3 | $0.27 | $0.03 | $0.08 | $0.07 |
| 2025Q2 | $0.25 | $0 | $0.03 | $0.03 |
MNKD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -17.75 |
| 2026Q1 | 0% | -11.36 |
| 2025Q4 | 0% | -27.47 |
| 2025Q3 | 0% | 51.63 |
| 2025Q2 | 0% | 425 |
MNKD
Price: $3.04
52 week price:
Earnings Per Share: -0.15 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.9 million
Ebitda: -28.5 millionMarket Capitalization: 1.2 billion